Infiltration of M2 tumor-associated macrophages in oral squamous cell carcinoma correlates with tumor malignancy

Cancers

Volumn 3, Issue 4, 2011, Pages 3726-3739

  Mori, Kazumasa ^a   Hiroi, Miki ^a   Shimada, Jun ^a   Ohmori, Yoshihiro ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

Alternatively activated macrophages; CD163; Immunohistochemical analysis; M2 macrophage; Oral squamous cell carcinoma; Tumor microenvironment; Tumor associated macrophage

Indexed keywords

B7 ANTIGEN; CD163 ANTIGEN; CD40 ANTIGEN; CD68 ANTIGEN;

ADULT; AGED; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CANCER GRADING; CANCER INFILTRATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; MALE; ORAL SQUAMOUS CELL CARCINOMA; PHENOTYPE; SQUAMOUS CELL CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR LOCALIZATION;

EID: 84055193356     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3043726     Document Type: Article

References (53)

1. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69-90.
2. Blot, W.J.; McLaughlin, J.K.; Winn, D.M.; Austin, D.F.; Greenberg, R.S.; Preston-Martin, S.; Bernstein, L.; Schoenberg, J.B.; Stemhagen, A.; Fraumeni, J.F., Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988, 48, 3282-3287.
3. Hennessey, P.T.; Westra, W.H.; Califano, J.A. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J. Dent. Res. 2009, 88, 300-306.
4. Adams, D.O.; Hamilton, T.A. The cell biology of macrophage activation. Annu. Rev. Immunol. 1984, 2, 283-318.
5. Hamilton, T.A.; Ohmori, Y.; Narumi, S.; Tannenbaum, C.S. Regulation of Diversity in Macrophage Activation. In Mononuclear Phagocytes in Cell Biology; Lopez-Berestein, G., Klostergaard, J., Eds.; CRC Press: New York, NY, USA, 1993; pp. 47-70.
6. Mantovani, A.; Sozzani, S.; Locati, M.; Allavena, P.; Sica, A. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23, 549-555.
7. Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3, 23-35.
8. Lau, S.K.; Chu, P.G.; Weiss, L.M. CD163: A specific marker of macrophages in paraffin-embedded tissue samples. Am. J. Clin. Pathol. 2004, 122, 794-801.
9. Komohara, Y.; Ohnishi, K.; Kuratsu, J.; Takeya, M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 2008, 216, 15-24.
10. van Dongen, M.; Savage, N.D.; Jordanova, E.S.; Briaire-de Bruijn, I.H.; Walburg, K.V.; Ottenhoff, T.H.; Hogendoorn, P.C.; van der Burg, S.H.; Gelderblom, H.; van Hall, T. Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors. Int. J. Cancer 2010, 127, 899-909.
11. Ohno, S.; Inagawa, H.; Dhar, D.K.; Fujii, T.; Ueda, S.; Tachibana, M.; Suzuki, N.; Inoue, M.; Soma, G.; Nagasue, N. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res. 2003, 23, 5015-5022.
12. Welsh, T.J.; Green, R.H.; Richardson, D.; Waller, D.A.; O'Byrne, K.J.; Bradding, P. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J. Clin. Oncol. 2005, 23, 8959-8967.
13. + T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer 2008, 113, 1387-1395.
14. Ma, J.; Liu, L.; Che, G.; Yu, N.; Dai, F.; You, Z. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 2010, 10, 112.
15. Ohri, C.M.; Shikotra, A.; Green, R.H.; Waller, D.A.; Bradding, P. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur. Respir. J. 2009, 33, 118-126.
16. Li, C.; Shintani, S.; Terakado, N.; Nakashiro, K.; Hamakawa, H. Infiltration of tumor-associated macrophages in human oral squamous cell carcinoma. Oncol. Rep. 2002, 9, 1219-1223.
17. El-Rouby, D.H. Association of macrophages with angiogenesis in oral verrucous and squamous cell carcinomas. J. Oral Pathol. Med. 2010, 39, 559-564.
18. Falini, B.; Flenghi, L.; Pileri, S.; Gambacorta, M.; Bigerna, B.; Durkop, H.; Eitelbach, F.; Thiele, J.; Pacini, R.; Cavaliere, A. et al. PG-M1: A new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am. J. Pathol. 1993, 142, 1359-1372.
19. Badylak, S.F.; Valentin, J.E.; Ravindra, A.K.; McCabe, G.P.; Stewart-Akers, A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng. Part A 2008, 14, 1835-1842.
20. Carreno, B.M.; Collins, M. The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 2002, 20, 29-53.
21. Freedman, A.S.; Freeman, G.J.; Rhynhart, K.; Nadler, L.M. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway. Cell. Immunol. 1991, 137, 429-437.
22. Buechler, C.; Ritter, M.; Orso, E.; Langmann, T.; Klucken, J.; Schmitz, G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J. Leukoc. Biol. 2000, 67, 97-103.
23. Moestrup, S.K.; Moller, H.J. CD163: A regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann. Med. 2004, 36, 347-354.
24. Pollard, J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004, 4, 71-78.
25. Tsutsui, S.; Yasuda, K.; Suzuki, K.; Tahara, K.; Higashi, H.; Era, S. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol. Rep. 2005, 14, 425-431.
26. Sica, A.; Saccani, A.; Bottazzi, B.; Polentarutti, N.; Vecchi, A.; van Damme, J.; Mantovani, A. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J. Immunol. 2000, 164, 762-767.
27. + regulatory T cells, which suppress via membrane-bound TGFbeta-1. J. Immunol. 2008, 181, 2220-2226.
28. Walter, S.; Govoni, D.; Bottazzi, B.; Mantovani, A. The role of macrophages in the regulation of primary tumor growth. Pathobiology 1991, 59, 239-242.
29. Ueno, T.; Toi, M.; Saji, H.; Muta, M.; Bando, H.; Kuroi, K.; Koike, M.; Inadera, H.; Matsushima, K. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res. 2000, 6, 3282-3289.
30. Duluc, D.; Delneste, Y.; Tan, F.; Moles, M.P.; Grimaud, L.; Lenoir, J.; Preisser, L.; Anegon, I.; Catala, L.; Ifrah, N. et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 2007, 110, 4319-4330.
31. Kawamura, K.; Komohara, Y.; Takaishi, K.; Katabuchi, H.; Takeya, M. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol. Int. 2009, 59, 300-305.
32. Stein, M.; Keshav, S.; Harris, N.; Gordon, S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. J. Exp. Med. 1992, 176, 287-292.
33. Edwards, J.P.; Zhang, X.; Frauwirth, K.A.; Mosser, D.M. Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol. 2006, 80, 1298-1307.
34. Fujieda, S.; Sunaga, H.; Tsuzuki, H.; Fan, G.K.; Saito, H. IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma. Cancer Lett. 1999, 136, 1-9.
35. Chandler, S.W.; Rassekh, C.H.; Rodman, S.M.; Ducatman, B.S. Immunohistochemical localization of interleukin-10 in human oral and pharyngeal carcinomas. Laryngoscope 2002, 112, 808-815.
36. Strauss, L.; Volland, D.; Kunkel, M.; Reichert, T.E. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): Possible link between angiogenesis and immune tolerance. Med. Sci. Monit. 2005, 11, BR280-BR292.
37. + peripheral blood mononuclear cells and induce M2-type macrophage polarization. J. Biol. Chem. 2009, 284, 34342-34354.
38. Ferreira, F.O.; Ribeiro, F.L.; Batista, A.C.; Leles, C.R.; de Cassia Goncalves Alencar, R.; Silva, T.A. Association of CCL2 with lymph node metastasis and macrophage infiltration in oral cavity and lip squamous cell carcinoma. Tumour Biol. 2008, 29, 114-121.
39. Sriuranpong, V.; Park, J.I.; Amornphimoltham, P.; Patel, V.; Nelkin, B.D.; Gutkind, J.S. Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res. 2003, 63, 2948-2956.
40. Sabourin, C.; Wang, Q.; Mallery, S.; Nicholson, R.; Gopalakrishnan, R.; Lang, J.; Schuller, D.; Stoner, G. Analysis of cytokine gene expression in squamous cell carcinoma of the head and neck. Int. J. Oncol. 1996, 8, 49-56.
41. Li, J.; Farthing, P.M.; Thornhill, M.H. Oral and skin keratinocytes are stimulated to secrete monocyte chemoattractant protein-1 by tumour necrosis factor-alpha and interferon-gamma. J. Oral Pathol. Med. 2000, 29, 438-444.
42. DeNardo, D.G.; Barreto, J.B.; Andreu, P.; Vasquez, L.; Tawfik, D.; Kolhatkar, N.; Coussens, L.M. CD4 T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009, 16, 91-102.
43. + regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. USA 2007, 104, 19446-19451.
44. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998, 58, 3491-3494.
45. Zhang, L.; Conejo-Garcia, J.R.; Katsaros, D.; Gimotty, P.A.; Massobrio, M.; Regnani, G.; Makrigiannakis, A.; Gray, H.; Schlienger, K.; Liebman, M.N. et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 2003, 348, 203-213.
46. + T-lymphocytes as a prognostic factor in human renal cell carcinoma: Clinicopathologic demonstration of antitumor immunity. Cancer Res. 2001, 61, 5132-5136.
47. Rabinovich, G.A.; Gabrilovich, D.; Sotomayor, E.M. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 2007, 25, 267-296.
48. + T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinoma. Int. J. Cancer 1997, 71, 178-182.
49. Ahmadzadeh, M.; Johnson, L.A.; Heemskerk, B.; Wunderlich, J.R.; Dudley, M.E.; White, D.E.; Rosenberg, S.A. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 2009, 114, 1537-1544.
50. Katou, F.; Ohtani, H.; Watanabe, Y.; Nakayama, T.; Yoshie, O.; Hashimoto, K. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer. Cancer Res. 2007, 67, 11195-11201.
51. Young, M.R.; Wright, M.A.; Lozano, Y.; Matthews, J.P.; Benefield, J.; Prechel, M.M. Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer. Int. J. Cancer 1996, 67, 333-338.
52. Pindborg, J.J.; Reichart, P.A.; van der Waal, I.; Sobin, L.H. Histological Typing of Cancer and Precancer of the Oral Mucosa, 2nd ed.; Springer: Berlin, Germany, 1997.
53. Barnes, L.; Eveson, J.; Reichart, P.; Sidransky, D. Pathology and Genetics of Head and Neck Tumours; IARC Press: Lyon, France, 2005; pp. 163-175.